Eli Lilly stock price forecast benefits from expanded reimbursement coverage for weight-loss therapies. This demand lift is projected to increase total revenue by double digits in 2025, reinforcing equity value in long-term portfolios. “It's always exciting when there's a different mechanism and it's an oral drug, so that's great,” says Snider. “It's a drug that's been around a while, and in prior iterations it did not meet efficacy endpoint, so that is where my enthusiasm for that is lower.” Our research shows that these estimate changes are directly correlated with near-term stock prices. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system. Short-term Eli Lilly stock price forecast points to consolidation near $850 before next upward leg. Chart patterns form ascending triangle, historically an indicator of breakout potential towards $